DERL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.036800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.634200E-01
Normal-vs-Stage2
2.108400E-01
Normal-vs-Stage3
1.543450E-01
Normal-vs-Stage4
1.294800E-01
Stage1-vs-Stage2
4.560800E-01
Stage1-vs-Stage3
3.358400E-01
Stage1-vs-Stage4
2.938800E-01
Stage2-vs-Stage3
4.714600E-01
Stage2-vs-Stage4
4.049200E-01
Stage3-vs-Stage4
9.337400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.897400E-01
Normal-vs-AfricanAmerican
7.437400E-01
Normal-vs-Asian
1.380230E-01
Caucasian-vs-AfricanAmerican
5.835700E-02
Caucasian-vs-Asian
9.985800E-01
AfricanAmerican-vs-Asian
2.984200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.231800E-01
Normal-vs-Female
4.297200E-01
Male-vs-Female
1.137190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.105800E-01
Normal-vs-Age(41-60Yrs)
5.487000E-01
Normal-vs-Age(61-80Yrs)
1.819800E-01
Normal-vs-Age(81-100Yrs)
6.257000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.082400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.703200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.069800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.438260E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.701200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.015800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.708230E-01
Normal-vs-Daily Drinker
9.839900E-02
Normal-vs-Weekly Drinker
5.724200E-01
Normal-vs-Occasional Drinker
5.686400E-01
Normal-vs-Social Drinker
1.030570E-01
Non Drinker-vs-Daily Drinker
8.185200E-01
Non Drinker-vs-Weekly Drinker
3.952600E-01
Non Drinker-vs-Occasional Drinker
2.761200E-01
Non Drinker-vs-Social Drinker
7.337000E-01
Daily Drinker-vs-Weekly Drinker
3.814000E-01
Daily Drinker-vs-Occasional Drinker
2.166200E-01
Daily Drinker-vs-Social Drinker
5.502800E-01
Weekly Drinker-vs-Occasional Drinker
9.224200E-01
Weekly Drinker-vs-Social Drinker
6.015000E-01
Occasional Drinker-vs-Social Drinker
4.466600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.762800E-01
Normal-vs-Grade 2
8.348600E-01
Normal-vs-Grade 3
8.265800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.608370E-02
Grade 1-vs-Grade 3
1.653920E-02
Grade 1-vs-Grade 4
9.762800E-01
Grade 2-vs-Grade 3
7.957000E-01
Grade 2-vs-Grade 4
8.348600E-01
Grade 3-vs-Grade 4
8.265800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.406440E-01
Normal-vs-NonDiabetic
3.400800E-01
Diabetic-vs-NonDiabetic
1.110960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.043800E-02
Normal-vs-NoPancreatitis
2.836800E-01
Pancreatitis-vs-NoPancreatitis
6.828600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.830200E-01
Normal-vs-N1
2.239600E-01
N0-vs-N1
2.190800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.902400E-02
Normal-vs-TP53-NonMutant
4.422200E-01
TP53-Mutant-vs-TP53-NonMutant
1.277560E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
